<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Ajsantos</id>
	<title>WikEM - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Ajsantos"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/wiki/Special:Contributions/Ajsantos"/>
	<updated>2026-05-18T19:39:12Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Giant_cell_arteritis&amp;diff=108658</id>
		<title>Giant cell arteritis</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Giant_cell_arteritis&amp;diff=108658"/>
		<updated>2016-11-01T04:58:55Z</updated>

		<summary type="html">&lt;p&gt;Ajsantos: /* Background */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Background==&lt;br /&gt;
*Systemic vasculitis most commonly involving medium-sized arteries in the carotid circulation affection 1% of the population&amp;lt;ref&amp;gt;Gonzalez-Gay, MA et al. Epidemiology of the vasculitides. Rheum Dis Clin North Am. 2001;27:729-749&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Giant cell arteritis, with possible involvement of large vessels like aorta leading to&amp;lt;ref&amp;gt;Morabito GC, Tartaglino B. Chapter 279. Emergencies in Systemic Rheumatic Diseases. In:  JE, Stapczynski JS, Cline DM, Ma OJ, Cydulka RK, Meckler GD, eds. 's Emergency Medicine: A Comprehensive Study Guide. 7th ed. New York: McGraw-Hil&amp;lt;/ref&amp;gt;:&lt;br /&gt;
**[[Temporal arteritis]]&lt;br /&gt;
**[[Aortic regurgitation]]&lt;br /&gt;
**Aortic arch syndrome&lt;br /&gt;
**[[Aortic dissection]]&lt;br /&gt;
*Elevated risk in Women and 50-70 yrs of age&lt;br /&gt;
*&amp;quot;Rule of 50s&amp;quot; can help remember useful points - &amp;quot;temporal arteritis affects patients at least 50 years of age, with a serum ESR &amp;gt; 50 mm/hr and is treated with 50mg of [[prednisone]] daily&amp;quot;&lt;br /&gt;
*Can cause painless, ischemic optic neuropathy with severe vision loss if left untreated&lt;br /&gt;
*Associated with [[polymyalgia rheumatica]] &amp;lt;ref&amp;gt; Lehrmann JF, Sercombe CT: Systemic Lupus Erythmatosus and the Vasculitides, in Marx JA, Hockberger RS, Walls RM, et al (eds): Rosen’s Emergency Medicine: Concepts and Clinical Practice, ed 7. St. Louis, Mosby, Inc., 2010, (Ch) 116: p 1497-1510.&amp;lt;/ref&amp;gt;&lt;br /&gt;
**50% of patients with Giant Cell Arteritis have concomitant Polymylalgia Rheumatica. 15% of patients with Polymyalgia Rheumatica develop Giant Cell Arteritis&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*[[Fever]]&lt;br /&gt;
*[[Headache]] in 85%&lt;br /&gt;
**Gradually worsens over days&lt;br /&gt;
**Worse at night&lt;br /&gt;
**Usually unilateral near temple&lt;br /&gt;
*Tender pulseless temporal artery&lt;br /&gt;
*Jaw claudication&lt;br /&gt;
**Weight Loss&lt;br /&gt;
*Myalgias (polymyalgia rheumatica)&lt;br /&gt;
*Visual loss in one eye in 50%&lt;br /&gt;
**Posterior ciliary artery&lt;br /&gt;
**May present as amaurosis fugax&lt;br /&gt;
**Second eye may be affected within weeks after first&lt;br /&gt;
===American College of Rheumatology Criteria&amp;lt;ref&amp;gt;Hunder GG. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.   Arthritis Rheum.  1990; 33(8):1122-8 &amp;lt;/ref&amp;gt;===&lt;br /&gt;
*3 or more criteria 93% sensitive and 91% specific&lt;br /&gt;
**Age ≥ 50 years old&lt;br /&gt;
**New onset of headache&lt;br /&gt;
**Temporal artery tenderness or DECREASED temporal pulse (not related to carotid disease)&lt;br /&gt;
**ESR ≥ 50 mm/hr&lt;br /&gt;
**Artery biopsy with necrotizing arteritis or a granulomatous process with multinucleated giant cells&lt;br /&gt;
&lt;br /&gt;
===Likelihood Ratio of Findings===&lt;br /&gt;
''Jaw claudication and a beaded temporal artery increase the likelihood of temporal arteritis the greatest''&amp;lt;ref&amp;gt;Smetana GW, et al. Does this patient have temporal arteritis? JAMA. 2002;287:92-101&amp;lt;/ref&amp;gt;&lt;br /&gt;
{| {{table}}&lt;br /&gt;
| align=&amp;quot;center&amp;quot; style=&amp;quot;background:#f0f0f0;&amp;quot;|'''Finding'''&lt;br /&gt;
| align=&amp;quot;center&amp;quot; style=&amp;quot;background:#f0f0f0;&amp;quot;|'''(+) Likelihood Ratio of Temporal Ateritis'''&lt;br /&gt;
| align=&amp;quot;center&amp;quot; style=&amp;quot;background:#f0f0f0;&amp;quot;|'''Negative Likelihood Ratio'''&lt;br /&gt;
|-&lt;br /&gt;
| Jaw claudication||4.2 (2.8-6.2)||0.72 (0.65 - 0.81)&lt;br /&gt;
|-&lt;br /&gt;
| Diplopia||3.4 (1.3-8.6)||0.95 (0.91 - 0.99)&lt;br /&gt;
|-&lt;br /&gt;
| Temporal artery beading||4.6 (1.1 - 18.4)||0.93 (0.88-0.99)&lt;br /&gt;
|-&lt;br /&gt;
| Enlarged temporal artery||4.3 (2.1-8.9)||0.67 (0.5-0.89)&lt;br /&gt;
|-&lt;br /&gt;
| Painful temporal artery||2.6 (1.9-3.7)||0.82 (0.74-0.92)&lt;br /&gt;
|-&lt;br /&gt;
| Absent temporal artery pulse||2.7 (0.55 - 13.4)||0.71 (0.38 - 1.3)&lt;br /&gt;
|-&lt;br /&gt;
| Abnormal ESR||1.1 (1.0-1.2)||0.2 (0.08 - 0.51)&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
{{Headache DDX}}&lt;br /&gt;
&lt;br /&gt;
{{Acute vision loss noninflamed DDX}}&lt;br /&gt;
&lt;br /&gt;
{{Primary Vasculitis DDX}}&lt;br /&gt;
&lt;br /&gt;
==Evaluation==&lt;br /&gt;
*Temporal artery tenderness&lt;br /&gt;
*Afferent pupillary defect&lt;br /&gt;
*Pale and edematous optic disc&lt;br /&gt;
*ESR ~70-110&lt;br /&gt;
**84% sensitivity, 30% specificity&amp;lt;ref&amp;gt;Kermani TA, et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012; 41:866–871.&amp;lt;/ref&amp;gt;&lt;br /&gt;
**&amp;gt;15% of patients can have a normal ESR&lt;br /&gt;
*CRP elevated&lt;br /&gt;
*4% of patients have normal CRP and ESR with biopsy confirmed diagnosis&amp;lt;ref&amp;gt;Jhun P, et al. Giant Cell Arteritis: Read the Fine Print!  Ann Em Med. 2015; 65(5):615–617.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
*[[Methylprednisolone]] 1000mg IV QD x3d&lt;br /&gt;
*Needs temporal artery biopsy&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*Admission&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Headache]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Ophthalmology]]&lt;br /&gt;
[[Category:Neurology]]&lt;br /&gt;
[[Category:Rheumatology]]&lt;/div&gt;</summary>
		<author><name>Ajsantos</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Gout_and_pseudogout&amp;diff=108657</id>
		<title>Gout and pseudogout</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Gout_and_pseudogout&amp;diff=108657"/>
		<updated>2016-11-01T04:14:43Z</updated>

		<summary type="html">&lt;p&gt;Ajsantos: /* Evaluation */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Pathophysiology==&lt;br /&gt;
*Primarily an illness of middle-aged males and elderly adults&lt;br /&gt;
*Gout in females occurs only after menopause&lt;br /&gt;
*Gout is most common form of inflammatory joint disease in men &amp;gt;40yr&lt;br /&gt;
*Presence of crystals does not exclude septic arthritis&lt;br /&gt;
&lt;br /&gt;
===Precipitants===&lt;br /&gt;
*Trauma&lt;br /&gt;
*Surgery&lt;br /&gt;
*Medication ([[allopurinol]], thiazide/loop diuretics, ASA)&lt;br /&gt;
*Alcohol consumption&lt;br /&gt;
*Meat/Seafood consumption &lt;br /&gt;
*Dehydration&lt;br /&gt;
*Lower body temperature&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*Joint pain may develop over period of hours&lt;br /&gt;
*Primarily involves first MTP, knee, ankle&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
{{Differential Diagnosis Monoarthritis}}&lt;br /&gt;
&lt;br /&gt;
==Evaluation==&lt;br /&gt;
*Synovial fluid aspiration&lt;br /&gt;
**Gout: yellow monosodium urate negative Negatively birefringent&lt;br /&gt;
**Pseudogout: calcium pyrophosphate positive birefringence crystals&lt;br /&gt;
&lt;br /&gt;
*Serum uric acid levels are not helpful (30% of patients with gout attack have normal levels)&lt;br /&gt;
**Uric acid during attacks will be low due to the precipiation of gout crystals&lt;br /&gt;
** High uric acid is &amp;lt;6.8 &lt;br /&gt;
*ESR may be elevated&lt;br /&gt;
*'''no bacteria on [[Gram Stain]]'''&lt;br /&gt;
*XR of joint space may have radiolucent calcium pyrophosphate formation as opposed to in [[gout]]&lt;br /&gt;
{{Arthrocentesis diagnostic chart}}&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
''Patients usually only require [[opioid]] and [[NSAID]] treatment in the ED with continued [[NSAID]] treatment as an oupatient. However any combination of the following treatments are acceptable&amp;lt;ref&amp;gt;Khanna D. et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res. Oct 2012;64(10):1447-61&amp;lt;/ref&amp;gt;''&lt;br /&gt;
&lt;br /&gt;
===[[NSAIDs]]===&lt;br /&gt;
*Do not give to patients with renal insufficiency (use [[opioids]] instead)&lt;br /&gt;
*Substantial pain relief should occur within 2hr&lt;br /&gt;
*Options:&lt;br /&gt;
**[[Indomethacin]] 50mg po TID x3-5d, OR&lt;br /&gt;
**[[Naproxen]] 500mg po BID x3-7d, OR&lt;br /&gt;
**[[Ibuprofen]] 800mg PO TID x 3-5d&lt;br /&gt;
&lt;br /&gt;
===Other options===&lt;br /&gt;
====[[Colchicine]]====&lt;br /&gt;
*Can be used as alternative agent to NSAIDs in patient with normal renal/hepatic function&lt;br /&gt;
*1.2mg PO (load), followed by 0.6mg one hour later x 1 &amp;lt;ref&amp;gt;Terkeltaub RA et al. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum. 2010;62(4):1060.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*May use to maximum of x3 doses, with more aggressive regimens totaling max dose up to 6mg&amp;lt;ref&amp;gt;GlobalRPH. http://www.globalrph.com/gout.htm*colchicine&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Wait at least x3 days before starting another round of colchicine therapy&lt;br /&gt;
*Renal impairment not absolute contraindication for acute flare but may consider dose reduction.&lt;br /&gt;
*Dose adjustments for CYP3A4 inhibitors (HARRT, Calcium Channel Blockers, fluconazole, erythromycin, clarithromycin)  &lt;br /&gt;
*Colchicine should not be administered intravenously&lt;br /&gt;
&lt;br /&gt;
Initial: 0.6-1.2mg, followed by 0.6 every 1-2 hours; some clinicians recommend a maximum of 3 doses; more aggressive approaches have recommended a maximum dose of up to 6mg. Wait at least 3 days before initiating another course of therapy&lt;br /&gt;
&lt;br /&gt;
====[[Steroids]]====&lt;br /&gt;
*[[Prednisone]] 30 to 50mg initially, and gradually tapered over 10 days, results in clinical resolution without rebound pain or complications&amp;lt;ref&amp;gt;Groff GD et al. Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum. 1990;19(6):329&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Janssens H. et al. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet. 2008;371(9627):1854.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Glucocorticoid injection====&lt;br /&gt;
*Even if gout has been diagnosed in the past, be cautious with glucocorticoid joint injection if the current clinical picture is uncertain since a [[Septic Arthritis|septic joint]] can coexist with gout and a steroid injection would then worsen the patient's clinical status.&lt;br /&gt;
&lt;br /&gt;
===All patients===&lt;br /&gt;
*Hold [[diuretics]]&lt;br /&gt;
*Consider starting [[losartan]] to replace diuretic (has modest uricosuric effect)&lt;br /&gt;
*Alcohol and dietary counseling&lt;br /&gt;
*Continue uric acid-lowering agents if already on prophylactic regimen (do not start)&lt;br /&gt;
*Follow up with Primary Doctor or Rheumatology if having continued flares&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Joint Pain]]&lt;br /&gt;
*[[Monoarticular Arthritis]]&lt;br /&gt;
*[[Knee Diagnoses]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
[[Category:Orthopedics]]&lt;br /&gt;
[[Category:Rheumatology]]&lt;/div&gt;</summary>
		<author><name>Ajsantos</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Gout_and_pseudogout&amp;diff=108654</id>
		<title>Gout and pseudogout</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Gout_and_pseudogout&amp;diff=108654"/>
		<updated>2016-11-01T04:12:05Z</updated>

		<summary type="html">&lt;p&gt;Ajsantos: /* Evaluation */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Pathophysiology==&lt;br /&gt;
*Primarily an illness of middle-aged males and elderly adults&lt;br /&gt;
*Gout in females occurs only after menopause&lt;br /&gt;
*Gout is most common form of inflammatory joint disease in men &amp;gt;40yr&lt;br /&gt;
*Presence of crystals does not exclude septic arthritis&lt;br /&gt;
&lt;br /&gt;
===Precipitants===&lt;br /&gt;
*Trauma&lt;br /&gt;
*Surgery&lt;br /&gt;
*Medication ([[allopurinol]], thiazide/loop diuretics, ASA)&lt;br /&gt;
*Alcohol consumption&lt;br /&gt;
*Meat/Seafood consumption &lt;br /&gt;
*Dehydration&lt;br /&gt;
*Lower body temperature&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*Joint pain may develop over period of hours&lt;br /&gt;
*Primarily involves first MTP, knee, ankle&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
{{Differential Diagnosis Monoarthritis}}&lt;br /&gt;
&lt;br /&gt;
==Evaluation==&lt;br /&gt;
*Synovial fluid aspiration&lt;br /&gt;
**Gout: yellow monosodium urate negative Negatively birefringent&lt;br /&gt;
**Pseudogout: calcium pyrophosphate positive birefringence crystals&lt;br /&gt;
&lt;br /&gt;
*Serum uric acid levels are not helpful (30% of patients with gout attack have normal levels)&lt;br /&gt;
*ESR may be elevated&lt;br /&gt;
*'''no bacteria on [[Gram Stain]]'''&lt;br /&gt;
*XR of joint space may have radiolucent calcium pyrophosphate formation as opposed to in [[gout]]&lt;br /&gt;
{{Arthrocentesis diagnostic chart}}&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
''Patients usually only require [[opioid]] and [[NSAID]] treatment in the ED with continued [[NSAID]] treatment as an oupatient. However any combination of the following treatments are acceptable&amp;lt;ref&amp;gt;Khanna D. et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res. Oct 2012;64(10):1447-61&amp;lt;/ref&amp;gt;''&lt;br /&gt;
&lt;br /&gt;
===[[NSAIDs]]===&lt;br /&gt;
*Do not give to patients with renal insufficiency (use [[opioids]] instead)&lt;br /&gt;
*Substantial pain relief should occur within 2hr&lt;br /&gt;
*Options:&lt;br /&gt;
**[[Indomethacin]] 50mg po TID x3-5d, OR&lt;br /&gt;
**[[Naproxen]] 500mg po BID x3-7d, OR&lt;br /&gt;
**[[Ibuprofen]] 800mg PO TID x 3-5d&lt;br /&gt;
&lt;br /&gt;
===Other options===&lt;br /&gt;
====[[Colchicine]]====&lt;br /&gt;
*Can be used as alternative agent to NSAIDs in patient with normal renal/hepatic function&lt;br /&gt;
*1.2mg PO (load), followed by 0.6mg one hour later x 1 &amp;lt;ref&amp;gt;Terkeltaub RA et al. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum. 2010;62(4):1060.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*May use to maximum of x3 doses, with more aggressive regimens totaling max dose up to 6mg&amp;lt;ref&amp;gt;GlobalRPH. http://www.globalrph.com/gout.htm*colchicine&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Wait at least x3 days before starting another round of colchicine therapy&lt;br /&gt;
*Renal impairment not absolute contraindication for acute flare but may consider dose reduction.&lt;br /&gt;
*Dose adjustments for CYP3A4 inhibitors (HARRT, Calcium Channel Blockers, fluconazole, erythromycin, clarithromycin)  &lt;br /&gt;
*Colchicine should not be administered intravenously&lt;br /&gt;
&lt;br /&gt;
Initial: 0.6-1.2mg, followed by 0.6 every 1-2 hours; some clinicians recommend a maximum of 3 doses; more aggressive approaches have recommended a maximum dose of up to 6mg. Wait at least 3 days before initiating another course of therapy&lt;br /&gt;
&lt;br /&gt;
====[[Steroids]]====&lt;br /&gt;
*[[Prednisone]] 30 to 50mg initially, and gradually tapered over 10 days, results in clinical resolution without rebound pain or complications&amp;lt;ref&amp;gt;Groff GD et al. Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum. 1990;19(6):329&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Janssens H. et al. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet. 2008;371(9627):1854.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Glucocorticoid injection====&lt;br /&gt;
*Even if gout has been diagnosed in the past, be cautious with glucocorticoid joint injection if the current clinical picture is uncertain since a [[Septic Arthritis|septic joint]] can coexist with gout and a steroid injection would then worsen the patient's clinical status.&lt;br /&gt;
&lt;br /&gt;
===All patients===&lt;br /&gt;
*Hold [[diuretics]]&lt;br /&gt;
*Consider starting [[losartan]] to replace diuretic (has modest uricosuric effect)&lt;br /&gt;
*Alcohol and dietary counseling&lt;br /&gt;
*Continue uric acid-lowering agents if already on prophylactic regimen (do not start)&lt;br /&gt;
*Follow up with Primary Doctor or Rheumatology if having continued flares&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Joint Pain]]&lt;br /&gt;
*[[Monoarticular Arthritis]]&lt;br /&gt;
*[[Knee Diagnoses]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
[[Category:Orthopedics]]&lt;br /&gt;
[[Category:Rheumatology]]&lt;/div&gt;</summary>
		<author><name>Ajsantos</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Gout_and_pseudogout&amp;diff=108653</id>
		<title>Gout and pseudogout</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Gout_and_pseudogout&amp;diff=108653"/>
		<updated>2016-11-01T04:11:19Z</updated>

		<summary type="html">&lt;p&gt;Ajsantos: /* Pathophysiology */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Pathophysiology==&lt;br /&gt;
*Primarily an illness of middle-aged males and elderly adults&lt;br /&gt;
*Gout in females occurs only after menopause&lt;br /&gt;
*Gout is most common form of inflammatory joint disease in men &amp;gt;40yr&lt;br /&gt;
*Presence of crystals does not exclude septic arthritis&lt;br /&gt;
&lt;br /&gt;
===Precipitants===&lt;br /&gt;
*Trauma&lt;br /&gt;
*Surgery&lt;br /&gt;
*Medication ([[allopurinol]], thiazide/loop diuretics, ASA)&lt;br /&gt;
*Alcohol consumption&lt;br /&gt;
*Meat/Seafood consumption &lt;br /&gt;
*Dehydration&lt;br /&gt;
*Lower body temperature&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*Joint pain may develop over period of hours&lt;br /&gt;
*Primarily involves first MTP, knee, ankle&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
{{Differential Diagnosis Monoarthritis}}&lt;br /&gt;
&lt;br /&gt;
==Evaluation==&lt;br /&gt;
*Synovial fluid aspiration&lt;br /&gt;
**Gout: monosodium urate negative Negatively birefringent&lt;br /&gt;
**Pseudogout: calcium pyrophosphate positive birefringence crystals&lt;br /&gt;
&lt;br /&gt;
*Serum uric acid levels are not helpful (30% of patients with gout attack have normal levels)&lt;br /&gt;
*ESR may be elevated&lt;br /&gt;
*'''no bacteria on [[Gram Stain]]'''&lt;br /&gt;
*XR of joint space may have radiolucent calcium pyrophosphate formation as opposed to in [[gout]]&lt;br /&gt;
{{Arthrocentesis diagnostic chart}}&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
''Patients usually only require [[opioid]] and [[NSAID]] treatment in the ED with continued [[NSAID]] treatment as an oupatient. However any combination of the following treatments are acceptable&amp;lt;ref&amp;gt;Khanna D. et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res. Oct 2012;64(10):1447-61&amp;lt;/ref&amp;gt;''&lt;br /&gt;
&lt;br /&gt;
===[[NSAIDs]]===&lt;br /&gt;
*Do not give to patients with renal insufficiency (use [[opioids]] instead)&lt;br /&gt;
*Substantial pain relief should occur within 2hr&lt;br /&gt;
*Options:&lt;br /&gt;
**[[Indomethacin]] 50mg po TID x3-5d, OR&lt;br /&gt;
**[[Naproxen]] 500mg po BID x3-7d, OR&lt;br /&gt;
**[[Ibuprofen]] 800mg PO TID x 3-5d&lt;br /&gt;
&lt;br /&gt;
===Other options===&lt;br /&gt;
====[[Colchicine]]====&lt;br /&gt;
*Can be used as alternative agent to NSAIDs in patient with normal renal/hepatic function&lt;br /&gt;
*1.2mg PO (load), followed by 0.6mg one hour later x 1 &amp;lt;ref&amp;gt;Terkeltaub RA et al. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum. 2010;62(4):1060.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*May use to maximum of x3 doses, with more aggressive regimens totaling max dose up to 6mg&amp;lt;ref&amp;gt;GlobalRPH. http://www.globalrph.com/gout.htm*colchicine&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Wait at least x3 days before starting another round of colchicine therapy&lt;br /&gt;
*Renal impairment not absolute contraindication for acute flare but may consider dose reduction.&lt;br /&gt;
*Dose adjustments for CYP3A4 inhibitors (HARRT, Calcium Channel Blockers, fluconazole, erythromycin, clarithromycin)  &lt;br /&gt;
*Colchicine should not be administered intravenously&lt;br /&gt;
&lt;br /&gt;
Initial: 0.6-1.2mg, followed by 0.6 every 1-2 hours; some clinicians recommend a maximum of 3 doses; more aggressive approaches have recommended a maximum dose of up to 6mg. Wait at least 3 days before initiating another course of therapy&lt;br /&gt;
&lt;br /&gt;
====[[Steroids]]====&lt;br /&gt;
*[[Prednisone]] 30 to 50mg initially, and gradually tapered over 10 days, results in clinical resolution without rebound pain or complications&amp;lt;ref&amp;gt;Groff GD et al. Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum. 1990;19(6):329&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Janssens H. et al. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet. 2008;371(9627):1854.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Glucocorticoid injection====&lt;br /&gt;
*Even if gout has been diagnosed in the past, be cautious with glucocorticoid joint injection if the current clinical picture is uncertain since a [[Septic Arthritis|septic joint]] can coexist with gout and a steroid injection would then worsen the patient's clinical status.&lt;br /&gt;
&lt;br /&gt;
===All patients===&lt;br /&gt;
*Hold [[diuretics]]&lt;br /&gt;
*Consider starting [[losartan]] to replace diuretic (has modest uricosuric effect)&lt;br /&gt;
*Alcohol and dietary counseling&lt;br /&gt;
*Continue uric acid-lowering agents if already on prophylactic regimen (do not start)&lt;br /&gt;
*Follow up with Primary Doctor or Rheumatology if having continued flares&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Joint Pain]]&lt;br /&gt;
*[[Monoarticular Arthritis]]&lt;br /&gt;
*[[Knee Diagnoses]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
[[Category:Orthopedics]]&lt;br /&gt;
[[Category:Rheumatology]]&lt;/div&gt;</summary>
		<author><name>Ajsantos</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Gout_and_pseudogout&amp;diff=108652</id>
		<title>Gout and pseudogout</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Gout_and_pseudogout&amp;diff=108652"/>
		<updated>2016-11-01T04:08:11Z</updated>

		<summary type="html">&lt;p&gt;Ajsantos: /* Pathophysiology */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Pathophysiology==&lt;br /&gt;
*Primarily an illness of middle-aged males and elderly adults&lt;br /&gt;
•Gout in females occurs only after menopause&lt;br /&gt;
*Gout is most common form of inflammatory joint disease in men &amp;gt;40yr&lt;br /&gt;
*Presence of crystals does not exclude septic arthritis&lt;br /&gt;
&lt;br /&gt;
===Precipitants===&lt;br /&gt;
*Trauma&lt;br /&gt;
*Surgery&lt;br /&gt;
*Medication ([[allopurinol]], thiazide/loop diuretics, ASA)&lt;br /&gt;
*Alcohol consumption&lt;br /&gt;
*Meat/Seafood consumption &lt;br /&gt;
*Dehydration&lt;br /&gt;
*Lower body temperature&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*Joint pain may develop over period of hours&lt;br /&gt;
*Primarily involves first MTP, knee, ankle&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
{{Differential Diagnosis Monoarthritis}}&lt;br /&gt;
&lt;br /&gt;
==Evaluation==&lt;br /&gt;
*Synovial fluid aspiration&lt;br /&gt;
**Gout: monosodium urate negative Negatively birefringent&lt;br /&gt;
**Pseudogout: calcium pyrophosphate positive birefringence crystals&lt;br /&gt;
&lt;br /&gt;
*Serum uric acid levels are not helpful (30% of patients with gout attack have normal levels)&lt;br /&gt;
*ESR may be elevated&lt;br /&gt;
*'''no bacteria on [[Gram Stain]]'''&lt;br /&gt;
*XR of joint space may have radiolucent calcium pyrophosphate formation as opposed to in [[gout]]&lt;br /&gt;
{{Arthrocentesis diagnostic chart}}&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
''Patients usually only require [[opioid]] and [[NSAID]] treatment in the ED with continued [[NSAID]] treatment as an oupatient. However any combination of the following treatments are acceptable&amp;lt;ref&amp;gt;Khanna D. et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res. Oct 2012;64(10):1447-61&amp;lt;/ref&amp;gt;''&lt;br /&gt;
&lt;br /&gt;
===[[NSAIDs]]===&lt;br /&gt;
*Do not give to patients with renal insufficiency (use [[opioids]] instead)&lt;br /&gt;
*Substantial pain relief should occur within 2hr&lt;br /&gt;
*Options:&lt;br /&gt;
**[[Indomethacin]] 50mg po TID x3-5d, OR&lt;br /&gt;
**[[Naproxen]] 500mg po BID x3-7d, OR&lt;br /&gt;
**[[Ibuprofen]] 800mg PO TID x 3-5d&lt;br /&gt;
&lt;br /&gt;
===Other options===&lt;br /&gt;
====[[Colchicine]]====&lt;br /&gt;
*Can be used as alternative agent to NSAIDs in patient with normal renal/hepatic function&lt;br /&gt;
*1.2mg PO (load), followed by 0.6mg one hour later x 1 &amp;lt;ref&amp;gt;Terkeltaub RA et al. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum. 2010;62(4):1060.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*May use to maximum of x3 doses, with more aggressive regimens totaling max dose up to 6mg&amp;lt;ref&amp;gt;GlobalRPH. http://www.globalrph.com/gout.htm*colchicine&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Wait at least x3 days before starting another round of colchicine therapy&lt;br /&gt;
*Renal impairment not absolute contraindication for acute flare but may consider dose reduction.&lt;br /&gt;
*Dose adjustments for CYP3A4 inhibitors (HARRT, Calcium Channel Blockers, fluconazole, erythromycin, clarithromycin)  &lt;br /&gt;
*Colchicine should not be administered intravenously&lt;br /&gt;
&lt;br /&gt;
Initial: 0.6-1.2mg, followed by 0.6 every 1-2 hours; some clinicians recommend a maximum of 3 doses; more aggressive approaches have recommended a maximum dose of up to 6mg. Wait at least 3 days before initiating another course of therapy&lt;br /&gt;
&lt;br /&gt;
====[[Steroids]]====&lt;br /&gt;
*[[Prednisone]] 30 to 50mg initially, and gradually tapered over 10 days, results in clinical resolution without rebound pain or complications&amp;lt;ref&amp;gt;Groff GD et al. Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum. 1990;19(6):329&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Janssens H. et al. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet. 2008;371(9627):1854.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Glucocorticoid injection====&lt;br /&gt;
*Even if gout has been diagnosed in the past, be cautious with glucocorticoid joint injection if the current clinical picture is uncertain since a [[Septic Arthritis|septic joint]] can coexist with gout and a steroid injection would then worsen the patient's clinical status.&lt;br /&gt;
&lt;br /&gt;
===All patients===&lt;br /&gt;
*Hold [[diuretics]]&lt;br /&gt;
*Consider starting [[losartan]] to replace diuretic (has modest uricosuric effect)&lt;br /&gt;
*Alcohol and dietary counseling&lt;br /&gt;
*Continue uric acid-lowering agents if already on prophylactic regimen (do not start)&lt;br /&gt;
*Follow up with Primary Doctor or Rheumatology if having continued flares&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Joint Pain]]&lt;br /&gt;
*[[Monoarticular Arthritis]]&lt;br /&gt;
*[[Knee Diagnoses]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
[[Category:Orthopedics]]&lt;br /&gt;
[[Category:Rheumatology]]&lt;/div&gt;</summary>
		<author><name>Ajsantos</name></author>
	</entry>
</feed>